Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of General Internal Medicine|February 21, 2008
Live, attenuated varicella zoster vaccination of an immunocompromised patientKelly K Curtis, Megan K Connolly, Donald W Northfelt
Critical Reviews in Oncology/Hematology|June 2, 2016
Past approaches and future directions for targeting tumor hypoxia in squamous cell carcinomas of the head and neckKelly K Curtis, William W Wong, Helen J Ross
Urology|November 10, 2007
Transfusion-dependent anemia after initiation of androgen deprivation therapy for metastatic prostate cancerKelly K Curtis, Rajiv K Pruthi, Rafael Fonseca, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|October 22, 2008
Anaemia following initiation of androgen deprivation therapy for metastatic prostate cancer: a retrospective chart reviewKelly K Curtis, Terrence J Adam, Shu-Chuan Chen, et al.
Targeted Oncology|May 3, 2021
Multicenter, Open-Label, Phase I Study of DSP-7888 Dosing Emulsion in Patients with Advanced MalignanciesAlexander Spira, Aaron R Hansen, Wael A Harb, et al.
Head & Neck|March 27, 2013
Transoral laser microsurgery followed by radiation therapy for oropharyngeal tumors: the Mayo Clinic Arizona experienceSamir H Patel, Michael L Hinni, Richard E Hayden, et al.
Radiation Oncology (London, England)|August 11, 2011
Neoadjuvant chemoradiation compared to neoadjuvant radiation alone and surgery alone for Stage II and III soft tissue sarcoma of the extremitiesKelly K Curtis, Jonathan B Ashman, Christopher P Beauchamp, et al.
Journal of Cancer|September 11, 2012
The impact of concomitant medication use on patient eligibility for phase I cancer clinical trialsMitesh J Borad, Kelly K Curtis, Hani M Babiker, et al.
Journal of Clinical Pharmacology|October 8, 2009
A phase I study to characterize the safety, tolerability, and pharmacokinetics of topotecan at 4 mg/m2 administered weekly as a 30-minute intravenous infusion in patients with cancerKelly K Curtis, Jean T Hartney, Roxanne C Jewell, et al.
Cancer Chemotherapy and Pharmacology|March 11, 2014
Novel LHRH-receptor-targeted cytolytic peptide, EP-100: first-in-human phase I study in patients with advanced LHRH-receptor-expressing solid tumorsKelly K Curtis, John Sarantopoulos, Donald W Northfelt, et al.
Pageof 2